Delivery Order SPE2DB22D2206-SPE2DB24FFD60
Award Date 1/18/24
Potential Completion Date 1/19/24
Potential Value $125K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,596.05 delivery order covers the supply of the medication Xifaxan 550 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,406.52 delivery order is for the supply of Xifaxan 550 mg tablets. The contract is a firm fixed-price Delivery Order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc. This IDC, valued at up to $999,999,999.00, serves as a...
- This federal contract award, valued at $23,835.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Xifaxan 550 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide...
- This federal contract award, identified as SPE2DB20D1004|SPE2DB21FG0T6, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,868.94 firm-fixed-price delivery order is for the supply of Xifaxan 550 mg tablets. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $6,582.22 firm fixed price delivery order is for the supply of Xifaxan 550 mg tablets, a brand name medication, to support military treatment programs and facilities. The award is associated with a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the drug Xifaxan 550 mg tablets. The delivery order has a firm fixed price of $2,666.97 and a completion date of June 6, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which enables the DLA to efficiently...
- This federal contract award is for the pharmaceutical product Xifaxan 550 mg tablets, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,969.73, was awarded by the Defense Logistics Agency (DLA) as a delivery order. It has a firm fixed price and an ultimate completion date of March 28, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Medical Supply Chain, which is part of the Defense Logistics Agency (DLA) Troop Support Medical, to Amerisourcebergen Drug Corp's Corporate Office Division. The $28,200.62 firm-fixed-price delivery order is for the supply of XIFAXAN 550 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, that allows the government to efficiently procure a...
- This federal contract award, valued at $5,533.78, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office division. The contract is a delivery order for the pharmaceutical product Xifaxan 550 mg tablet, 60 count. The contract has an ultimate completion date of August 23, 2024 and is a firm fixed-price contract type. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,036.52, is for the delivery of Xifaxan 550 mg tablets and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...